Advertisement

FortuneIndia

Quick Links :

Fortune 500 India
40 Under 40
Most Powerful Women
Budget 2024
India's Richest
The Next 500
Best B-Schools
Opinion
First Edit
Multimedia
Events

Fortune 500 India
40 Under 40
Most Powerful Women
The Next 500
Best B-Schools
All Rankings
Events
Macro
Enterprise
Technology
Reviews
Venture
Investing
Multimedia
Fortune India Exchange
Bystander
Opinion
Infographics
Ideas
Long Reads
People
Buy on Amazon
Polemicist
Annual Subscription

astrazeneca pharma

Share

September 2024

AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges

AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

By Shabeeh Azeem

Advertisement

Top Stories

Piyush Goyal urges India Inc to utilise $12 bn research fund

Piyush Goyal urges India Inc to utilise $12 bn research fund

RBI governor Das calls for balance in managing inflation to support economic growth

RBI governor Das calls for balance in managing inflation to support economic growth

Karnataka looks to boost space sector investments

Karnataka looks to boost space sector investments

‘No reduction in number of securities’: BSE, NSE clarify on margin funding

‘No reduction in number of securities’: BSE, NSE clarify on margin funding

93% Indian executives anticipate a cyber-budget increase next year: PwC

93% Indian executives anticipate a cyber-budget increase next year: PwC

Advertisement

Advertisement

Top Stories

Piyush Goyal urges India Inc to utilise $12 bn research fund

Piyush Goyal urges India Inc to utilise $12 bn research fund

RBI governor Das calls for balance in managing inflation to support economic growth

RBI governor Das calls for balance in managing inflation to support economic growth

Karnataka looks to boost space sector investments

Karnataka looks to boost space sector investments

‘No reduction in number of securities’: BSE, NSE clarify on margin funding

‘No reduction in number of securities’: BSE, NSE clarify on margin funding

93% Indian executives anticipate a cyber-budget increase next year: PwC

93% Indian executives anticipate a cyber-budget increase next year: PwC

Contact Us
Vision & Core Values
Terms of Use
Privacy & Cookie Policy